186 related articles for article (PubMed ID: 37118807)
1. Lycorine transfersomes modified with cell-penetrating peptides for topical treatment of cutaneous squamous cell carcinoma.
Li Y; Tai Z; Ma J; Miao F; Xin R; Shen C; Shen M; Zhu Q; Chen Z
J Nanobiotechnology; 2023 Apr; 21(1):139. PubMed ID: 37118807
[TBL] [Abstract][Full Text] [Related]
2. Enhanced Transdermal Drug Delivery by Transfersome-Embedded Oligopeptide Hydrogel for Topical Chemotherapy of Melanoma.
Jiang T; Wang T; Li T; Ma Y; Shen S; He B; Mo R
ACS Nano; 2018 Oct; 12(10):9693-9701. PubMed ID: 30183253
[TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor receptor promotes progression of cutaneous squamous cell carcinoma.
Khandelwal AR; Kent B; Hillary S; Alam MM; Ma X; Gu X; DiGiovanni J; Nathan CO
Mol Carcinog; 2019 Oct; 58(10):1715-1725. PubMed ID: 31254372
[TBL] [Abstract][Full Text] [Related]
4. Dual inhibition of epidermal growth factor receptor and insulin-like growth factor receptor I: reduction of angiogenesis and tumor growth in cutaneous squamous cell carcinoma.
Galer CE; Corey CL; Wang Z; Younes MN; Gomez-Rivera F; Jasser SA; Ludwig DL; El-Naggar AK; Weber RS; Myers JN
Head Neck; 2011 Feb; 33(2):189-98. PubMed ID: 20848439
[TBL] [Abstract][Full Text] [Related]
5. Development of a MEK inhibitor, NFX-179, as a chemoprevention agent for squamous cell carcinoma.
Sarin KY; Kincaid J; Sell B; Shahryari J; Duncton MAJ; Morefield E; Sun W; Prieto K; Chavez-Chiang O; de Moran Segura C; Nguyen J; Bronson RT; Plotkin SR; Kochendoerfer GG; Fenn P; Wootton MA; Powala C; de Souza MP; Tsai KY
Sci Transl Med; 2023 Oct; 15(717):eade1844. PubMed ID: 37820007
[TBL] [Abstract][Full Text] [Related]
6. Topical arginase inhibition decreases growth of cutaneous squamous cell carcinoma.
Mittal A; Wang M; Vidyarthi A; Yanez D; Pizzurro G; Thakral D; Tracy E; Colegio OR
Sci Rep; 2021 May; 11(1):10731. PubMed ID: 34031449
[TBL] [Abstract][Full Text] [Related]
7. Facial cutaneous squamous cell carcinoma - microscopic safety margins and their impact on developing local recurrences.
Thiem DGE; Scharr K; Pabst AM; Saka B; Kämmerer PW
J Craniomaxillofac Surg; 2020 Jan; 48(1):49-55. PubMed ID: 31810842
[TBL] [Abstract][Full Text] [Related]
8. Topical kinase inhibitors induce regression of cutaneous squamous cell carcinoma.
Yang X; Daifallah AEM; Shankar S; Beer J; Marshall C; Dentchev T; Seykora F; D'Armas S; Hahn J; Lee V; Sabry HH; Farag AM; Seykora JT
Exp Dermatol; 2019 May; 28(5):609-613. PubMed ID: 30762245
[TBL] [Abstract][Full Text] [Related]
9. Liquid Crystalline Nanodispersions Functionalized with Cell-Penetrating Peptides for Topical Delivery of Short-Interfering RNAs: A Proposal for Silencing a Pro-Inflammatory Cytokine in Cutaneous Diseases.
Petrilli R; Eloy JO; Praça FS; Del Ciampo JO; Fantini MA; Fonseca MJ; Bentley MV
J Biomed Nanotechnol; 2016 May; 12(5):1063-75. PubMed ID: 27305826
[TBL] [Abstract][Full Text] [Related]
10. Expression of Programmed Cell Death Ligand in Cutaneous Squamous Cell Carcinoma and Treatment of Locally Advanced Disease With Pembrolizumab.
Stevenson ML; Wang CQ; Abikhair M; Roudiani N; Felsen D; Krueger JG; Pavlick AC; Carucci JA
JAMA Dermatol; 2017 Apr; 153(4):299-303. PubMed ID: 28259107
[TBL] [Abstract][Full Text] [Related]
11. Alkannin exerts antitumor properties in cutaneous squamous cell carcinoma by inducing apoptosis and shifting the M1/M2 polarization of tumor-associated macrophages by upregulating PTEN.
Zhang ZZ; Wen CH; Jia M; Zhang HQ; Sun SQ
Kaohsiung J Med Sci; 2023 Jan; 39(1):70-79. PubMed ID: 36367154
[TBL] [Abstract][Full Text] [Related]
12. The Synthetic Flavonoid Derivative GL-V9 Induces Apoptosis and Autophagy in Cutaneous Squamous Cell Carcinoma via Suppressing AKT-Regulated HK2 and mTOR Signals.
Zhu Y; Liu M; Yao J; Guo Q; Wei L
Molecules; 2020 Oct; 25(21):. PubMed ID: 33143000
[TBL] [Abstract][Full Text] [Related]
13. The impact of propranolol on apoptosis in cutaneous squamous cell carcinomas.
Celik E; Kaplan HM; Singirik E
Bratisl Lek Listy; 2020; 121(11):801-804. PubMed ID: 33164541
[TBL] [Abstract][Full Text] [Related]
14. Outcomes of Patients With Multiple Cutaneous Squamous Cell Carcinomas: A 10-Year Single-Institution Cohort Study.
Levine DE; Karia PS; Schmults CD
JAMA Dermatol; 2015 Nov; 151(11):1220-5. PubMed ID: 26177278
[TBL] [Abstract][Full Text] [Related]
15. Crocin exerts anti-proliferative and apoptotic effects on cutaneous squamous cell carcinoma via miR-320a/ATG2B.
Bi X; Jiang Z; Luan Z; Qiu D
Bioengineered; 2021 Dec; 12(1):4569-4580. PubMed ID: 34320900
[TBL] [Abstract][Full Text] [Related]
16. GDC-0084 inhibits cutaneous squamous cell carcinoma cell growth.
Ding LT; Zhao P; Yang ML; Lv GZ; Zhao TL
Biochem Biophys Res Commun; 2018 Sep; 503(3):1941-1948. PubMed ID: 30072096
[TBL] [Abstract][Full Text] [Related]
17. METTL3 mediated m
Zhou R; Gao Y; Lv D; Wang C; Wang D; Li Q
Biochem Biophys Res Commun; 2019 Jul; 515(2):310-317. PubMed ID: 31153635
[TBL] [Abstract][Full Text] [Related]
18. MiR-199a-5p represses the stemness of cutaneous squamous cell carcinoma stem cells by targeting Sirt1 and CD44ICD cleavage signaling.
Lu RH; Xiao ZQ; Zhou JD; Yin CQ; Chen ZZ; Tang FJ; Wang SH
Cell Cycle; 2020 Jan; 19(1):1-14. PubMed ID: 31809227
[TBL] [Abstract][Full Text] [Related]
19. Huaier Inhibits Proliferation, Migration, and Invasion of Cutaneous Squamous Cell Carcinoma Cells by Inhibiting the Methylation Levels of CDKN2A and TP53.
Wang L; Xu L; Wang Y
Integr Cancer Ther; 2021; 20():15347354211031646. PubMed ID: 34291682
[TBL] [Abstract][Full Text] [Related]
20. Cationic membrane-active peptides - anticancer and antifungal activity as well as penetration into human skin.
Do N; Weindl G; Grohmann L; Salwiczek M; Koksch B; Korting HC; Schäfer-Korting M
Exp Dermatol; 2014 May; 23(5):326-31. PubMed ID: 24661024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
